EGFR and non-small cell lung carcinoma: Detection of micro-EGFR T790M mutations using ddPCR and eliminating FFPE-derived false positive mutation will be helpful in selecting optimal EGFR-TKI regimens for patients with EGFR-mutated NSCLC.